Related by context. Frequent words. (Click for all words.) 66 forodesine 65 Phase IIa clinical trials 65 Phase 2b clinical trials 65 GVAX R 65 refractory chronic lymphocytic 63 phase IIb clinical 63 CORT # 62 dose cohorts 62 multi kinase inhibitor 62 R sorafenib tablets 62 elotuzumab 62 Allovectin 7 R 62 Panzem R 62 dacetuzumab 62 Phase IIb trials 62 phase Ib 62 Inovio clinical 62 RGB # 62 Entereg R 61 Phase Ib II 61 ALN VSP 61 AEG# 61 advanced carcinoid 61 virus HCV infection 61 non alcoholic steatohepatitis 61 SAR# [004] 61 HGS ETR1 61 relapsed refractory multiple myeloma 60 rheumatoid arthritis psoriasis 60 forodesine HCl 60 drug conjugate ADC 60 PEG SN# 60 Phase Ib clinical 60 ongoing Phase 1b 60 IMC #B 59 squalamine 59 immunological diseases 59 IMC A# 59 metastatic castration resistant 59 investigational compounds 59 Presents Positive 59 Phase 1b trial 59 ApoB SNALP 59 phase IIa clinical 59 Daclizumab 59 Phase III clinical trials 59 Phase 1b clinical 59 Thiarabine 59 INCB# [001] 59 Pivotal Phase 59 multicenter Phase 59 vosaroxin 59 Completes Enrollment 59 registrational trial 59 deforolimus 59 Aurexis 58 Nanobody 58 drug conjugate 58 ThermoDox R 58 docetaxel chemotherapy 58 liposomal formulation 58 placebo controlled Phase 58 L Annamycin 58 CR# vcMMAE 58 Phase 2a clinical 58 multiple sclerosis rheumatoid arthritis 58 Asentar 58 dose escalation trial 58 sodium Injection 58 Inc. Nasdaq SGEN 58 TOCOSOL Paclitaxel 58 registrational 58 Hepatitis C HCV 58 refractory multiple myeloma 58 Pivotal Phase III 58 Initiate Phase 58 preclinical compounds 58 Copegus R 58 Phase Ib 58 Tesetaxel 58 Inc. Nasdaq IMGN 58 GLPG# 58 Phase IIa trial 58 teplizumab 57 colorectal lung 57 GRNVAC1 57 please visit http:/www.supergen.com 57 Phase 2a trial 57 MEK inhibitor 57 Indibulin 57 post herpetic neuralgia PHN 57 TELCYTA 57 Pegasys ® 57 KRN# 57 proteasome inhibitor 57 pertuzumab 57 Azedra 57 developing Zerenex TM 57 phase IIa 57 sunitinib malate 57 hepatitis C HCV